- D82.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D82.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D82.0 – other international versions of ICD-10 D82.0 may differ.
ICD-10-CM D82.0 is grouped within Diagnostic Related Group(s):
- 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
- 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
- 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc
Applicable To
- Immunodeficiency with thrombocytopenia and eczema
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D82.0:
- with thrombocytopenia and eczema > cell-mediated D84.89
- thrombocytopenia and eczema > with D81.30
- Aldrich (-Wiskott) > Syndrome
- eczema-thrombocytopenia > Syndrome
- familial eczema-thrombocytopenia (Wiskott-Aldrich) > Syndrome
- Wiskott-Aldrich > Syndrome